the competition, page-4

Abu;

Don't forget that VCR have also managed to introduce a new patented technology that allow the Ventrassist to monitor and regulate blood flow to match the patient's exersion. This is something that the competion (any of them) has yet to achieve.

Also don't forget that VCR had a lousey PR, investor relations, and complete lack of understanding on how to cultivate strong financial backing.

This summarises and encapsulate the same questions and issues poster on here and other sites have been asking.